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Cancer cells have means to inﬂ uence other cells in their vicinity and distant, and in 
this signal-delivering mechanisms the chaperonin Hsp60 plays a role, which is current-
ly being recognized as potentially crucial for the growth and dissemination of at least 
certain types of tumors. In order to arrive at its destination, Hsp60, a typical resident of 
mitochondria in normal and tumor cells, leaves the organelle and reaches the blood. In 
the latter, Hsp60 can travel and arrive at targets situated far away from its origin. The 
details of the route followed by Hsp60 and their molecular mechanisms have not yet 
been fully elucidated. We investigated Hsp60 levels and secretion in normal and tumor 
cell lines. We traced Hsp60 in whole-cell lysates; culture medium; purifi ed exosomes, 
membranes, and lipid rafts; and samples for electron microscopy (EM); using various 
complementary techniques, for example electrophoresis, ultracentrifugation, West-
ern blotting, ELISA, enzymatic tests, EM and immuno-EM, and enzymatic digestions 
and determinations. Exosomes were purifi ed and assessed by EM and by determining 
presence of ALIX, Hsp90 alpha and beta, and Hsp70, and by measuring ATPase and 
AChE activities. To obtain information on the secretion routes that might be involved, 
we used inhibitors of the lipid raft and exosome pathways. We found that the tumor 
but not the normal cell lines studied secreted Hsp60 actively (cell death and destruction 
did not play a role in the chaperonin exiting the tumor cells in our experiments). The 
data also showed that the lipid rafts-exosome pathways were defi nitely involved. We 
then established that Hsp60 associated with the cell membrane, lipid rafts, and exoso-
mal membrane. We integrated all the data into a model that could serve as a blueprint 
for future experiments aiming at fi lling in the missing information. This working mod-
el includes the following stages: Hsp60 in the cytosol, coming either from mitochon-
dria or from synthesis in it without entering the organelle, reaches the cell membrane 
and binds lipid rafts, and through lipid-raft mediated endocytosis is included in early 
endosomes and then in multivesicular bodies and, fi nally, in exosomes for secretion. 
Extracellular exosomes may then reach: a) inﬂ ammatory cells and/or other components 
of the immune system such as neutrophils and macrophages to elicit inﬂ ammation and 
adaptive-type of immune responses; b) endothelial cells to induce neoangiogenesis; and 
c) other tumor cells to act as anti-apoptotic factors and promote cancer survival.
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